Clinical outcomes of pancreatic ductal adenocarcinoma resection following neoadjuvant chemoradiation therapy vs. chemotherapy

Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial

(2013) Fuyuhiko Motoi et al.   ANNALS OF SURGICAL ONCOLOGY

Influence of preoperative anti-cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: Project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery

(2013) Fuyuhiko Motoi et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Long-Term Results of Surgical Resection After Preoperative Chemoradiation in Patients With Pancreatic Cancer

(2012) Sohei Satoi et al.   PANCREAS

Neo-adjuvant Chemoradiation Therapy Using S-1 Followed by Surgical Resection in Patients with Pancreatic Cancer

(2011) Sohei Satoi et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas

(2011) Yuji Nimura et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Retrospective Evaluation of the Influence of Postoperative Tumor Marker Status on Survival and Patterns of Recurrence After Surgery for Pancreatic Cancer Based on RECIST Guidelines

(2010) Fuyuhiko Motoi et al.   ANNALS OF SURGICAL ONCOLOGY

Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma

(2009) Thomas Schnelldorfer et al.   ANNALS OF SURGERY

Feasibility and Efficacy of Combination Therapy With Preoperative Full-Dose Gemcitabine, Concurrent Three-Dimensional Conformal Radiation, Surgery, and Postoperative Liver Perfusion Chemotherapy for T3-Pancreatic Cancer

(2009) Hiroaki Ohigashi et al.   ANNALS OF SURGERY

Prospective Phase II Trial of Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Resectable Adenocarcinoma of the Pancreatic Head

(2008) Stefan Heinrich et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

(2008) Douglas B. Evans et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-Term Survival (5-20 Years) After Pancreatectomy for Pancreatic Ductal Adenocarcinoma

(2008) Mustapha Adham et al.   PANCREAS